Literature DB >> 21463712

Differential serum cytokine levels are associated with cytokine gene polymorphisms in north Indians with active pulmonary tuberculosis.

Irengbam Rocky Mangangcha, Pankaj Jha, Komal Arora, Mitali Mukerji, Jayant Nagesh Banavaliker, Vani Brahmachari, Mridula Bose.   

Abstract

Globally only 5-10% of people encountering Mycobacterium tuberculosis have a lifetime risk of active disease indicating a strong host genetic bias towards development of tuberculosis. In the current study we investigated genotype variants pertaining to five cytokine genes namely IFNG, TNFA, IL4, IL10 and IL12 in the north Indian population with active pulmonary tuberculosis (APTB) and correlated the serum cytokine levels with the corresponding genotypes. Twenty five single nucleotide polymorphisms (SNPs) including six loci examined for the first time in tuberculosis were selected for genotyping in 108 patients with APTB from north India and 48 healthy regional controls (HC). Applying exclusion criteria 12 SNPs passed all the filters and were analysed further. The serum cytokine concentrations were measured by ELISA. Compared to HC mean serum IFN-γ, IL-12, IL-4, and IL-10 levels were higher in APTB (p = 0.3661, p = 0.0186, p = 0.003, p = 0.7, respectively). In contrast the mean serum TNF-α level was higher in HC (p = 0.007). Comparison of genotypes and serum levels of the corresponding cytokine genes reveal that though IFN-γ and IL-4 levels were higher in APTB the genotype variants showed no difference between HC and APTB. In contrast the genotypes of the selected rsIDs in the TNFA, IL12 and IL10 genes showed significant association with the varying serum levels of corresponding cytokines. The variant of the TNFA gene at rs3093662, the IL12 gene at rs3213094 and rs3212220 and the IL10 gene at rs3024498 did show a strong indication to be of relevance to the immunity to tuberculosis. To our knowledge this is the first report from this region relating genotypes and serum cytokine levels in north Indian population.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21463712     DOI: 10.1016/j.meegid.2011.03.017

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  15 in total

1.  StIL-17 gene polymorphisms in the development of pulmonary tuberculosis.

Authors:  Jin Du; Jichang Han; Xiandong Li; Yajun Zhang; Hongbing Li; Shujuan Yang
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

2.  Associations between cytokine gene variations and severe persistent breast pain in women following breast cancer surgery.

Authors:  Kimberly Stephens; Bruce A Cooper; Claudia West; Steven M Paul; Christina R Baggott; John D Merriman; Anand Dhruva; Kord M Kober; Dale J Langford; Heather Leutwyler; Judith A Luce; Brian L Schmidt; Gary M Abrams; Charles Elboim; Deborah Hamolsky; Jon D Levine; Christine Miaskowski; Bradley E Aouizerat
Journal:  J Pain       Date:  2013-10-12       Impact factor: 5.820

3.  Coassociations between IL10 polymorphisms, IL-10 production, helminth infection, and asthma/wheeze in an urban tropical population in Brazil.

Authors:  Camila Alexandrina Figueiredo; Maurício Lima Barreto; Neuza Maria Alcantara-Neves; Laura Cunha Rodrigues; Philip John Cooper; Alvaro A Cruz; Lain Carlos Pontes-de-Carvalho; Denise C Lemaire; Ryan dos Santos Costa; Leila D Amorim; Candelaria Vergara; Nicholas Rafaels; Li Gao; Cassandra Foster; Monica Campbell; Rasika A Mathias; Kathleen C Barnes
Journal:  J Allergy Clin Immunol       Date:  2012-12-28       Impact factor: 10.793

Review 4.  Association of polymorphism +874 A/T of interferon-γ and susceptibility to the development of tuberculosis: meta-analysis.

Authors:  A C de Albuquerque; L Q Rocha; A H de Morais Batista; A B Teixeira; D B Dos Santos; N A P Nogueira
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-09       Impact factor: 3.267

5.  Footprints of genetic susceptibility to pulmonary tuberculosis: cytokine gene variants in north Indians.

Authors:  Mridula Bose; Pankaj Jha
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

6.  Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes.

Authors:  Paul Arora; Bibiana Garcia-Bailo; Zari Dastani; Darren Brenner; Andre Villegas; Suneil Malik; Timothy D Spector; Brent Richards; Ahmed El-Sohemy; Mohamed Karmali; Alaa Badawi
Journal:  BMC Med Genet       Date:  2011-07-14       Impact factor: 2.103

7.  IL10 Variant g.5311A Is Associated with Visceral Leishmaniasis in Indian Population.

Authors:  Anshuman Mishra; Sheikh Nizamuddin; Geethika Arekatla; Satya Prakash; Hemlata Dewangan; Abishai Dominic; Abhishek Mishra; Digumarthi V S Sudhakar; Narasimha R Parine; Nitin C Tupperwar; Kumarasamy Thangaraj
Journal:  PLoS One       Date:  2015-05-05       Impact factor: 3.240

8.  Evaluation of TNF-α, IL-10 and IL-6 Cytokine Production and Their Correlation with Genotype Variants amongst Tuberculosis Patients and Their Household Contacts.

Authors:  Lavanya Joshi; Meenakshi Ponnana; Ramya Sivangala; Lakshmi Kiran Chelluri; Prathiba Nallari; Sitaramaraju Penmetsa; Vijayalakshmi Valluri; Sumanlatha Gaddam
Journal:  PLoS One       Date:  2015-09-11       Impact factor: 3.240

9.  No association of IFNG+874T/A SNP and NOS2A-954G/C SNP variants with nitric oxide radical serum levels or susceptibility to tuberculosis in a Brazilian population subset.

Authors:  Ana Cristina C S Leandro; Márcia Andrade Rocha; Andreia Lamoglia-Souza; John L VandeBerg; Valeria Cavalcanti Rolla; Maria da Gloria Bonecini-Almeida
Journal:  Biomed Res Int       Date:  2013-08-18       Impact factor: 3.411

10.  Cytokine Polymorphisms, Their Influence and Levels in Brazilian Patients with Pulmonary Tuberculosis during Antituberculosis Treatment.

Authors:  Eliana Peresi; Larissa Ragozo Cardoso Oliveira; Weber Laurentino da Silva; Erika Alessandra Pellison Nunes da Costa; João Pessoa Araujo; Jairo Aparecido Ayres; Maria Rita Parise Fortes; Edward A Graviss; Ana Carla Pereira; Sueli Aparecida Calvi
Journal:  Tuberc Res Treat       Date:  2013-03-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.